Leadership of The Cancer Institute of New Jersey

Robert S. DiPaola, MD Director
Susan Goodin, PharmD Deputy Director and Associate Director for Clinical Trials and Therapeutics	Edmund C. Lattime, PhD Deputy Director Associate Director for Education and Training Director, New Jersey State Cancer Registry and Principal Investigator, NCI-SEER Registry

Joseph Aisner, MD Associate Director for Clinical Science	John J. Graff, PhD, MS Chief, Division of Bioinformatics and Surveillance
David A. August, MD Chief, Surgical Oncology	Bruce G. Haffty, MD Chair, Radiation Oncology
Linda Barker Chief Administrative Officer and Associate Director for Administration and Planning	Isaac Kim, MD, PhD Chief, Urologic Oncology
Joseph R. Bertino, MD Chief Scientific Officer	Sharon Manne, PhD Chief, Population Studies
Kevin Coyle Executive Director of Finance	Lorna Rodriguez, MD, PhD Director, Precision Medicine
Richard Drachtman, MD Interim Chief, Pediatric Hematology/Oncology	Roger Strair, MD, PhD Chief, Hematologic Malignancies/ Hematopoietic Stem Cell Transplantation
David J. Foran, PhD Chief Informatics Officer and Executive Director of Biomedical Informatics	Deborah L. Toppmeyer, MD Chief Medical Officer and Chief, Solid Tumor Oncology
Shridar Ganesan, MD, PhD Associate Director for Translational Science	Eileen White, PhD Associate Director for Basic Science
Darlene G. Gibbon, MD Chief, Gynecologic Oncology	Helmut Zarbl, PhD Associate Director for Public Health Science

Research